ClinConnect ClinConnect Logo
Search / Trial NCT05374616

Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder

Launched by BAYLOR COLLEGE OF MEDICINE · May 13, 2022

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding a condition called TANGO2-related Disorder, which is caused by specific changes in the TANGO2 gene. Researchers aim to create a collection of biological samples, known as a biorepository, from individuals who have this genetic disorder. This collection will help scientists study the disease and build a detailed database to learn more about how it affects patients over time.

The trial is currently looking for participants of all ages who have been diagnosed with TANGO2-related Disorder due to changes in the TANGO2 gene. If your child or a family member has this condition, they may be eligible to join the study. Participants can expect to provide samples and information that will contribute to important research. This is a great opportunity to help advance our understanding of this disorder and potentially improve care for others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients with pathogenic TANGO2 variants will be included.
  • Exclusion Criteria:
  • Patients who do not have TANGO2-related disease will be excluded.

About Baylor College Of Medicine

Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials